Literature DB >> 26353734

Factorial Design and Development of Solid Lipid Nanoparticles (SLN) for Gene Delivery.

Allan Radaic, Eneida de Paula, Marcelo Bispo de Jesus.   

Abstract

Several scientific hurdles still have to be overcome before gene therapy becomes a reality. One of them is the development of safe and efficient gene delivery system. Here, we have employed factorial design to optimize the production of solid lipid nanoparticles (SLN) for gene delivery. A 2 x 3 full-factorial experimental design was used for the optimization of SLNs formulations. The variables were defined by the components of the formulation: concentration of stearic acid, DOTAP, and Pluronic F68 at two levels (-1, 1) and 3 central points (0). Different SNL formulations were prepared by varying the amount of components and several properties were tested, including their capacity to accommodate DNA and protection against DNase degradation, colloidal stability, in vitro cytotoxicity, and transfection efficiency in prostate cancer cells. Finally, response Surface Methodology was used to select the most effective formulation for gene delivery to prostate cancer cells in vitro. In conclusion, this study revealed that stearic acid and Pluronic F68 were determinant to SLN size and stability, respectively, while small amounts of DOTAP are essential for a successful transfection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26353734     DOI: 10.1166/jnn.2015.9002

Source DB:  PubMed          Journal:  J Nanosci Nanotechnol        ISSN: 1533-4880


  4 in total

1.  The in vivo toxicological profile of cationic solid lipid nanoparticles.

Authors:  Monique Culturato Padilha Mendonça; Allan Radaic; Fernanda Garcia-Fossa; Maria Alice da Cruz-Höfling; Marco Aurélio Ramirez Vinolo; Marcelo Bispo de Jesus
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

Review 2.  Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Therapeutics.

Authors:  Brittany E Givens; Youssef W Naguib; Sean M Geary; Eric J Devor; Aliasger K Salem
Journal:  AAPS J       Date:  2018-10-10       Impact factor: 4.009

Review 3.  Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.

Authors:  Jörgen Elgqvist
Journal:  Int J Mol Sci       Date:  2017-05-20       Impact factor: 5.923

4.  Formulation and Development of Transferrin Targeted Solid Lipid Nanoparticles for Breast Cancer Therapy.

Authors:  Geeta S Bhagwat; Rajani B Athawale; Rajeev P Gude; Shadab Md; Nabil A Alhakamy; Usama A Fahmy; Prashant Kesharwani
Journal:  Front Pharmacol       Date:  2020-11-27       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.